Create an Account - Increase your productivity, customize your experience, and engage in information you care about.
Currently, two manufacturers are experiencing a shortage of vaccine and immunoglobulin used for rabies PEP. This has affected the local supply chain of these products, which are now in short supply.
Suspected rabies exposure is a notifiable condition for health care providers and health care facilities in Washington (WAC 246-101-101 and -301, respectively). The intent to administer rabies PEP should trigger immediate notification of SHD CD at 425.339.5278. During that reporting communication, SHD CD can provide consultation and recommendations regarding use of PEP and access to the immunobiologics needed, if appropriate.
To mitigate unnecessary use of PEP, whenever safe and feasible after an exposure, efforts should be made to capture the animal and hold it for observation (e.g., domestic cat, dog, or ferret) or euthanize and test it promptly for rabies (e.g., bats, wild or feral animals). SHD CD can provide guidance regarding observation parameters and will facilitate testing of animals when appropriate.